Germany
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.29 B
|
Dec. 31, 2023 | USD 123.08 | 5.04% |
|
Germany |
|
2 |
USD 425.27 M
|
Dec. 31, 2023 | USD 42.86 | 0.25% |
|
Germany |
|
3 |
USD 205.73 M
|
Dec. 31, 2023 | USD 3.80 | 5.15% |
|
Germany |
|
4 |
USD 76.50 M
|
Dec. 31, 2023 | USD 55.66 | 3.14% |
|
Germany |
|
5 |
USD 21.53 M
|
Nov. 30, 2023 | USD 2.56 | 1.91% |
|
Germany |
|
6 |
USD 18.59 M
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
|
7 |
USD 7.92 M
|
Dec. 31, 2023 | USD 1.71 | -2.14% |
|
Germany |
|
8 |
USD 3.51 M
|
Dec. 31, 2023 | USD 2.04 | 1.81% |
|
Germany |
|
9 |
USD 743.27 K
|
Dec. 31, 2023 | USD 1.44 | 1.72% |
|
Germany |
The Vaccines company in Germany with the highest Current Liabilities is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 2.29 B.
The Vaccines company in Germany with the lowest Current Liabilities is NanoRepro AG (XETRA: NN6.DE) at USD 743.27 K.
The top 10 Vaccines companies in Germany by Current Liabilities are BioNTech SE, Biotest AG, CureVac N.V., Formycon AG, Heidelberg Pharma AG, InflaRx N.V., Medigene AG, Vivoryon Therapeutics N.V. and NanoRepro AG.
The bottom 10 Vaccines companies in Germany by Current Liabilities are NanoRepro AG, Vivoryon Therapeutics N.V., Medigene AG, InflaRx N.V., Heidelberg Pharma AG, Formycon AG, CureVac N.V., Biotest AG and BioNTech SE.